Jingyue Wang

846 citations
52 papers · 572 indexed · 1 hit paper · h-index 13

Jingyue Wang

46 papers receiving 561 citations

Hit Papers

GLP−1 receptor agonists for the treatment of obesity: Rol...153202320262024202550100150

Peers

Jingyue Wang
Comparison fields: 5 of 113
  • Endocrinology, Diabetes and Metabolism 103
  • Rehabilitation 40
  • Molecular Medicine 21
  • Biomaterials 55
  • Pharmacology 52
Replace Qingqing Wang with:
Qingqing Wang China
Sha Zhang China
Jingyi Hu China
Qiaoling Yang China
Natalia Moreno‐Castellanos Colombia
Meng Xin China
Amira Hassouna Egypt
Saurav Kumar Jha India
Elisha R. Injeti United States
Jingyue Wang relative to Qingqing Wang China Qingqing Wang's profile →
Citations per field
00.5×
Qingqing Wang · 1×
Citations per year

Countries citing papers authored by Jingyue Wang

Since Specialization
Citations

This map shows the geographic impact of Jingyue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyue Wang more than expected).

Fields of papers citing papers by Jingyue Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyue Wang. The network helps show where Jingyue Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jingyue Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jingyue Wang Line = papers co-authored together Jingyue Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20253
3 20251
4 20246
5 20247
6 20241
7 20246
8 20247
9 202314
10 20234
11 20236
12 202212
13 20221
14 202210
15 202212
16 20221
17 202111
18 20216
19 202110
20 20201

About Jingyue Wang

Jingyue Wang is a scholar working on Biotechnology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 52 papers that have together received 572 indexed citations. Recurring topics across this work include Gut microbiota and health (6 papers), Ginseng Biological Effects and Applications (5 papers), Enzyme Production and Characterization (4 papers), Microbial Metabolites in Food Biotechnology (4 papers), Thermochemical Biomass Conversion Processes (4 papers), Natural Fiber Reinforced Composites (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Flavonoids in Medical Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (103 citations), Rehabilitation (40 citations) and Molecular Medicine (21 citations). Jingyue Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Quanwei Wang, Wei Yang, Jingyu Jin, Xinyu Yang, Xianfeng Zhang, Shuangmin Chen, Tong Zhou, Ying Liu, Zhenxiang Yu and Dan Zou. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Journal of Asian Natural Products Research, Cell Death and Disease, Frontiers in Pharmacology and Energy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026